Upgrade to SI Premium - Free Trial

JPMorgan Downgrades Dyne Therapeutics (DYN) to Underweight

September 8, 2026 4:26 PM
JPMorgan analyst Tessa Romero downgraded Dyne Therapeutics (NASDAQ: DYN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades